Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
23.60
+1.43 (6.45%)
At close: Mar 9, 2026, 4:00 PM EDT
23.57
-0.03 (-0.12%)
After-hours: Mar 9, 2026, 7:54 PM EDT
Neurogene Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 366 | 340 | 249 | - | - |
| Market Cap Growth | 42.17% | 36.64% | - | - | - |
| Enterprise Value | 110 | 214 | 452 | - | - |
| Last Close Price | 23.60 | 22.86 | 19.38 | - | - |
| PE Ratio | - | - | 18.20 | - | - |
| PS Ratio | - | 367.11 | - | - | - |
| PB Ratio | 1.31 | 1.09 | 1.34 | - | - |
| P/TBV Ratio | 1.38 | 1.09 | 1.34 | - | - |
| EV/Sales Ratio | - | 231.03 | - | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.08 | 0.05 | 0.06 |
| Net Debt / Equity Ratio | -0.96 | -0.97 | -0.98 | -0.78 | -0.76 |
| Net Debt / EBITDA Ratio | 2.71 | 3.79 | 3.48 | 1.45 | 1.32 |
| Net Debt / FCF Ratio | 3.26 | 4.20 | 3.52 | 1.41 | 1.01 |
| Asset Turnover | - | 0.00 | - | - | - |
| Quick Ratio | 18.10 | 20.65 | 8.61 | 12.48 | 6.57 |
| Current Ratio | 18.39 | 20.84 | 8.72 | 12.74 | 6.81 |
| Return on Equity (ROE) | -42.25% | -30.28% | -25.52% | -59.77% | - |
| Return on Assets (ROA) | -26.91% | -18.47% | -20.94% | -33.52% | - |
| Return on Capital Employed (ROCE) | -35.60% | -25.70% | -27.80% | -55.10% | -55.80% |
| Earnings Yield | -23.29% | -22.13% | -14.61% | - | - |
| FCF Yield | -21.45% | -21.03% | -20.82% | - | - |
| Buyback Yield / Dilution | -60.75% | -277.22% | -1080.37% | 90.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.